FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis
South San Francisco, CA — December 14, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Home »
South San Francisco, CA — December 14, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
13 November 2020 — GlaxoSmithKline plc (GSK) today announced further progression in its R&D pipeline with presentation of data for …
Why ARE so many young people obese? At 15, Harry weighed 18 STONE – so big he needed hip surgery… …
Which of these is not a risk factor for prediabetes? A) Overweight B) Age 45 or older C) Being white …
A new evaluation strategy for assessing stress, allostatic load and distress has been found of clinical value in a trial …
The United States health care system is generally centered around hospitals and specialty care. The value of primary care, however, …